Russia’s Health Ministry cancels Dekaris registration, removes 10 more drugs

Russia’s Health Ministry canceled the state registration of 11 medicines. Registration for the anthelmintic Dekaris (levamisole) was terminated based on a Federal Service for Surveillance in Healthcare conclusion that it posed a health risk, while the other 10 were removed at the manufacturers’ request.

Russia’s Health Ministry decided to cancel the state registration of 11 medicines and remove them from the state register. The documents were signed by Deputy Health Minister Sergey Glagolev on October 23 and 29, 2026, and the information was published in the State Register of Medicines.

The only medicine whose registration was terminated at the regulator’s initiative was the anthelmintic Dekaris (levamisole), in 50- and 150-milligram tablets manufactured by Gedeon Richter. The decision of October 29 was made under Article 32 of the law on the circulation of medicines and based on a conclusion issued by the Federal Service for Surveillance in Healthcare on October 14 concerning a threat to human health from medicines containing the active ingredient levamisole.

Модель молекулы левамизола — действующего вещества «Декариса»

The other 10 decisions were made at the request of the marketing authorization holders. The list includes four medicines from Teva, the antibiotic Betaclav, four medicines from the Moscow Pharmaceutical Factory and medical oxygen manufactured by the Rosenergoatom concern.

Patients who have been prescribed medicines from the list should consult a doctor about selecting a replacement.